Pages that link to "Q28260293"
Jump to navigation
Jump to search
The following pages link to BRAF(V599E) mutation is the leading genetic event in adult sporadic papillary thyroid carcinomas (Q28260293):
Displaying 50 items.
- BRAF mutations in hairy-cell leukemia (Q24609980) (← links)
- Clinical, genetic, and immunohistochemical characterization of 70 Ukrainian adult cases with post-Chornobyl papillary thyroid carcinoma (Q24616408) (← links)
- Ameloblastoma: A Review of Recent Molecular Pathogenetic Discoveries (Q26781648) (← links)
- Time to re-consider the meaning of BRAF V600E mutation in papillary thyroid carcinoma (Q26853261) (← links)
- Targeting mitochondrial metabolism by inhibiting autophagy in BRAF-driven cancers (Q27022240) (← links)
- A knowledge network for a dynamic taxonomy of psychiatric disease (Q27025656) (← links)
- RASSF1A and NORE1A methylation and BRAFV600E mutations in thyroid tumors (Q28258450) (← links)
- New insights into the diagnosis of nodular goiter (Q33827492) (← links)
- Loss of CPSF2 expression is associated with increased thyroid cancer cellular invasion and cancer stem cell population, and more aggressive disease (Q33837093) (← links)
- Medical history, lifestyle, and occupational risk factors for hairy cell leukemia: the InterLymph Non-Hodgkin Lymphoma Subtypes Project (Q34137904) (← links)
- P2X7 protein expression and polymorphism in non-small cell lung cancer (NSCLC) (Q34152239) (← links)
- BRAF mutation may predict higher necessity of postoperative radioactive iodine ablation in papillary thyroid cancer (Q34335766) (← links)
- Association of BRAFV600E mutation with clinicopathological features of papillary thyroid carcinoma: a study on a Chinese population (Q34501707) (← links)
- High rate of BRAF and RET/PTC dual mutations associated with recurrent papillary thyroid carcinoma (Q34572289) (← links)
- Testing computational prediction of missense mutation phenotypes: functional characterization of 204 mutations of human cystathionine beta synthase (Q34579607) (← links)
- Association between BRAF V600E mutation and recurrence of papillary thyroid cancer. (Q34716574) (← links)
- Targeted Treatment of Differentiated and Medullary Thyroid Cancer (Q35147151) (← links)
- BRAF gene: From human cancers to developmental syndromes (Q35802430) (← links)
- RET/PTC Translocations and Clinico-Pathological Features in Human Papillary Thyroid Carcinoma. (Q35971877) (← links)
- Intracellular signal transduction and modification of the tumor microenvironment induced by RET/PTCs in papillary thyroid carcinoma (Q35977327) (← links)
- Aberrant expression of COT is related to recurrence of papillary thyroid cancer (Q36152396) (← links)
- BRAFV600E status and clinical characteristics in solitary and multiple papillary thyroid carcinoma: experience of 512 cases at a clinical center in China (Q36167898) (← links)
- Detection of BRAF V600E activating mutation in papillary thyroid carcinoma using PCR with allele-specific fluorescent probe melting curve analysis (Q36172170) (← links)
- Alterations of the BRAF gene in thyroid tumors. (Q36318125) (← links)
- MEK1/2 Inhibitors: Molecular Activity and Resistance Mechanisms (Q36328021) (← links)
- Differential Clinicopathological Risk and Prognosis of Major Papillary Thyroid Cancer Variants. (Q36431628) (← links)
- Understanding the genotype of follicular thyroid tumors (Q36455078) (← links)
- RET receptor signaling: dysfunction in thyroid cancer and Hirschsprung's disease. (Q36458528) (← links)
- Poorly differentiated and anaplastic thyroid cancer (Q36493228) (← links)
- Osteopontin expression in papillary thyroid carcinoma and its relationship with the BRAF mutation and tumor characteristics (Q36514930) (← links)
- Analysis of human MDM4 variants in papillary thyroid carcinomas reveals new potential markers of cancer properties (Q36609221) (← links)
- Mutations and deregulation of Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascades which alter therapy response (Q36862768) (← links)
- Simalikalactone E (SkE), a new weapon in the armamentarium of drugs targeting cancers that exhibit constitutive activation of the ERK pathway (Q36926143) (← links)
- Molecular genetics of papillary thyroid carcinoma: great expectations (Q36949765) (← links)
- Clinical prognosis in BRAF-mutated PTC. (Q36949784) (← links)
- Changes in the clinicopathological characteristics and outcomes of thyroid cancer in Korea over the past four decades. (Q36991347) (← links)
- Molecular genetics of thyroid cancer: implications for diagnosis, treatment and prognosis (Q37035285) (← links)
- What is New on Thyroid Cancer Biomarkers (Q37207279) (← links)
- Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer (Q37216703) (← links)
- Molecular pathology of thyroid cancer: diagnostic and clinical implications (Q37337504) (← links)
- Surgical implications of B-RafV600E mutation in fine-needle aspiration of thyroid nodules (Q37431090) (← links)
- B-RAF V600E mutational analysis of fine needle aspirates correlates with diagnosis of thyroid nodules (Q37459366) (← links)
- Differentiated thyroid tumors: surgical indications (Q37560570) (← links)
- Molecular pathogenesis of nodular goiter (Q37864598) (← links)
- The pituitary tumor transforming gene in thyroid cancer (Q38004366) (← links)
- Reoperative central compartment dissection for patients with recurrent/persistent papillary thyroid cancer: efficacy, safety, and the association of the BRAF mutation (Q38006850) (← links)
- Papillary microcarcinoma of the thyroid: clinical characteristics and BRAF(V600E) mutational status of 977 cases (Q38078223) (← links)
- BRAF mutation in cytology samples as a diagnostic tool for papillary thyroid carcinoma (Q38088737) (← links)
- Molecular diagnosis for indeterminate thyroid nodules on fine needle aspiration: advances and limitations (Q38124903) (← links)
- Genetics and epigenetics of sporadic thyroid cancer (Q38128097) (← links)